2020 ESMO/EURACAN临床实践指南：肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访

2020-08-24 欧洲肿瘤内科学会 Ann Oncol . 2020 Aug 24;

2020年8月，欧洲肿瘤内科学会(ESMO)联合欧洲成人罕见实体瘤网(EURACAN)共同发布了肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访指南。指南主要内容涉及肾上腺皮质癌和恶性嗜铬细胞瘤的流行

中文标题：

英文标题：

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-08-24

简要介绍：

2020年8月，欧洲肿瘤内科学会(ESMO)联合欧洲成人罕见实体瘤网(EURACAN)共同发布了肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访指南。指南主要内容涉及肾上腺皮质癌和恶性嗜铬细胞瘤的流行病学，分期和危险因素，局部病灶的管理，晚期和转移性疾病的管理，监测和随访。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=1b4df1c001968eec, title=2020 ESMO/EURACAN临床实践指南：肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访, enTitle=Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up, guiderFrom=Ann Oncol . 2020 Aug 24;, authorId=0, author=, summary=2020年8月，欧洲肿瘤内科学会(ESMO)联合欧洲成人罕见实体瘤网(EURACAN)共同发布了肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访指南。指南主要内容涉及肾上腺皮质癌和恶性嗜铬细胞瘤的流行, cover=https://img.medsci.cn/2020910/1599671809360_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Mon Aug 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，欧洲肿瘤内科学会(ESMO)联合欧洲成人罕见实体瘤网(EURACAN)共同发布了肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访指南。指南主要内容涉及肾上腺皮质癌和恶性嗜铬细胞瘤的流行病学，分期和危险因素，局部病灶的管理，晚期和转移性疾病的管理，监测和随访。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=11634, tagName=嗜铬细胞瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11634, guiderKeyword=嗜铬细胞瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5321, appHits=355, showAppHits=0, pcHits=1339, showPcHits=4966, likes=2, shares=14, comments=36, approvalStatus=1, publishedTime=Thu Sep 10 01:37:10 CST 2020, publishedTimeString=2020-08-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 10 01:19:17 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:32:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肾上腺皮质癌和恶性嗜铬.pdf)])

肾上腺皮质癌和恶性嗜铬.pdf

下载请点击：

评论区 (25)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1240018, encodeId=765a1240018e1, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07065554794, createdName=Karl24, createdTime=Sat Aug 20 20:00:57 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204244, encodeId=b60f1204244fa, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Sun Mar 20 08:46:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186115, encodeId=e3e811861159f, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Wed Jan 19 19:05:33 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051269, encodeId=b5d1105126913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a485472875, createdName=ms2000000982990246, createdTime=Tue Sep 14 21:09:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978665, encodeId=8e809e8665bc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b715537225, createdName=ms1000001942143464, createdTime=Thu Jul 01 16:42:04 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
2022-08-20 Karl24

学习一下

82 0
[GetPortalCommentsPageByObjectIdResponse(id=1240018, encodeId=765a1240018e1, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07065554794, createdName=Karl24, createdTime=Sat Aug 20 20:00:57 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204244, encodeId=b60f1204244fa, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Sun Mar 20 08:46:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186115, encodeId=e3e811861159f, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Wed Jan 19 19:05:33 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051269, encodeId=b5d1105126913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a485472875, createdName=ms2000000982990246, createdTime=Tue Sep 14 21:09:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978665, encodeId=8e809e8665bc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b715537225, createdName=ms1000001942143464, createdTime=Thu Jul 01 16:42:04 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
2022-03-20 ms2000001010425621

！

81 0
[GetPortalCommentsPageByObjectIdResponse(id=1240018, encodeId=765a1240018e1, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07065554794, createdName=Karl24, createdTime=Sat Aug 20 20:00:57 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204244, encodeId=b60f1204244fa, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Sun Mar 20 08:46:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186115, encodeId=e3e811861159f, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Wed Jan 19 19:05:33 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051269, encodeId=b5d1105126913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a485472875, createdName=ms2000000982990246, createdTime=Tue Sep 14 21:09:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978665, encodeId=8e809e8665bc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b715537225, createdName=ms1000001942143464, createdTime=Thu Jul 01 16:42:04 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
2022-01-19 ms2000001010425621

学习了！

77 0
[GetPortalCommentsPageByObjectIdResponse(id=1240018, encodeId=765a1240018e1, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07065554794, createdName=Karl24, createdTime=Sat Aug 20 20:00:57 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204244, encodeId=b60f1204244fa, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Sun Mar 20 08:46:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186115, encodeId=e3e811861159f, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Wed Jan 19 19:05:33 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051269, encodeId=b5d1105126913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a485472875, createdName=ms2000000982990246, createdTime=Tue Sep 14 21:09:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978665, encodeId=8e809e8665bc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b715537225, createdName=ms1000001942143464, createdTime=Thu Jul 01 16:42:04 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
2021-09-14 ms2000000982990246

学习了

94 0
[GetPortalCommentsPageByObjectIdResponse(id=1240018, encodeId=765a1240018e1, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07065554794, createdName=Karl24, createdTime=Sat Aug 20 20:00:57 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204244, encodeId=b60f1204244fa, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Sun Mar 20 08:46:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186115, encodeId=e3e811861159f, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6bc5505693, createdName=ms2000001010425621, createdTime=Wed Jan 19 19:05:33 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051269, encodeId=b5d1105126913, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a485472875, createdName=ms2000000982990246, createdTime=Tue Sep 14 21:09:27 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978665, encodeId=8e809e8665bc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b715537225, createdName=ms1000001942143464, createdTime=Thu Jul 01 16:42:04 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
2021-07-01 ms1000001942143464

很好

95 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2020 ESMO/EURACAN临床实践指南：肾上腺皮质癌和恶性嗜铬细胞瘤的诊断，治疗以及随访

相关指南

拓展阅读

科室

工具

服务